What Is The Long-term Outlook for AMC Stock?
Meme stock extraordinaire AMC Entertainment Holdings, Inc. (NYSE:AMC) has long…
Sell
50
ABT Quote, Financials, Valuation and Earnings
Last price:
$137.38
Seasonality move
:
2.73%
Day range:
$132.38 - $139.06
52-week range:
$99.71 - $141.23
Dividend yield:
1.65%
P/E ratio:
17.91x
P/S ratio:
5.70x
P/B ratio:
4.92x
Volume:
9.9M
Avg. volume:
6.1M
1-year change:
31.13%
Market cap:
$240.2B
Revenue:
$42B
EPS (TTM):
$7.71
Earnings Data
Next earnings date for ABT
Jul 18
2025
Most recent earnings per share
$0.76
Missed by $0.31
(Apr 16/2025)
Consensus Estimate
$1.07
(Apr 16/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ABT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 07/18/2025 | Q2 | $11B | -- | -- | $1.25 | -- |
| 04/16/2025 | Q1 | $10.4B | $10.4B | $0.76 | $1.07 | -$0.31 |
| 01/22/2025 | Q4 | $11B | $11B | $5.27 | $1.34 | $3.93 |
| 10/16/2024 | Q3 | $10.6B | $10.6B | $0.94 | $1.20 | -$0.26 |
| 07/18/2024 | Q2 | $10.4B | $10.4B | $0.74 | $1.10 | -$0.36 |
| 04/17/2024 | Q1 | $9.9B | $10B | $0.70 | $0.95 | -$0.25 |
| 01/24/2024 | Q4 | $10.2B | $10.2B | $0.91 | $1.19 | -$0.28 |
| 10/18/2023 | Q3 | $9.8B | $10.1B | $0.82 | $1.10 | -$0.28 |
| 07/20/2023 | Q2 | $9.7B | $10B | $0.78 | $1.05 | -$0.27 |
| 04/19/2023 | Q1 | $9.6B | $9.7B | $0.75 | $0.99 | -$0.24 |
| 01/25/2023 | Q4 | -- | $10.1B | $0.59 | -- | -- |
| 10/19/2022 | Q3 | -- | $10.4B | $0.81 | -- | -- |
| 07/20/2022 | Q2 | -- | $11.3B | $1.14 | -- | -- |
| 04/20/2022 | Q1 | -- | $11.9B | $1.37 | -- | -- |
| 01/26/2022 | Q4 | -- | $11.5B | $1.11 | -- | -- |
| 10/20/2021 | Q3 | -- | $10.9B | $1.17 | -- | -- |
| 07/22/2021 | Q2 | -- | $10.2B | $0.66 | -- | -- |
| 04/20/2021 | Q1 | -- | $10.5B | $1.00 | -- | -- |
| 01/27/2021 | Q4 | -- | $10.7B | $1.20 | -- | -- |
| 10/21/2020 | Q3 | -- | $8.9B | $0.69 | -- | -- |
| 07/16/2020 | Q2 | -- | $7.3B | $0.30 | -- | -- |
| 04/16/2020 | Q1 | -- | $7.7B | $0.31 | -- | -- |
| 01/22/2020 | Q4 | -- | $8.3B | $0.59 | -- | -- |
| 10/16/2019 | Q3 | -- | $8.1B | $0.53 | -- | -- |
| 07/17/2019 | Q2 | -- | $8B | $0.56 | -- | -- |
| 04/17/2019 | Q1 | -- | $7.5B | $0.38 | -- | -- |
| 01/23/2019 | Q4 | -- | $7.8B | $0.37 | -- | -- |
| 10/17/2018 | Q3 | -- | $7.7B | $0.32 | -- | -- |
| 07/18/2018 | Q2 | -- | $7.8B | $0.41 | -- | -- |
| 04/18/2018 | Q1 | -- | $7.4B | $0.23 | -- | -- |
| 01/24/2018 | Q4 | -- | $7.6B | -$0.48 | -- | -- |
| 10/18/2017 | Q3 | -- | $6.8B | $0.34 | -- | -- |
| 07/20/2017 | Q2 | -- | $6.6B | $0.16 | -- | -- |
| 04/19/2017 | Q1 | -- | $6.3B | $0.24 | -- | -- |
| 01/25/2017 | Q4 | -- | $5.3B | $0.53 | -- | -- |
| 10/19/2016 | Q3 | -- | $5.3B | -$0.22 | -- | -- |
| 07/20/2016 | Q2 | -- | $5.3B | $0.41 | -- | -- |
| 04/20/2016 | Q1 | -- | $4.9B | $0.21 | -- | -- |
| 01/28/2016 | Q4 | -- | $5.2B | $0.51 | -- | -- |
| 10/21/2015 | Q3 | -- | $5.2B | $0.38 | -- | -- |
| 07/22/2015 | Q2 | -- | $5.2B | $0.52 | -- | -- |
Abbott Laboratories Earnings Questions
-
How Much did Abbott Laboratories Generate in Revenue Last Quarter?
Abbott Laboratories reported $10.4B worth of top line sales in its most recent quarter.
-
Did Abbott Laboratories Beat Earnings Last Quarter?
Abbott Laboratories announced earnings per share of $0.76 which represents a miss of analyst forecast a $1.07 per share.
-
Is Abbott Laboratories Profitable?
Abbott Laboratories reported $5.9B that represents $3.37 per share over the last quarter.
-
What is the Analyst Consensus for Abbott Laboratories EPS Next Year?
Abbott Laboratories's earnings are forecast to decrease from $7.64 per share to $4.67 per share next year representing a decrease of -32.51%.
-
When is Abbott Laboratories's Earnings Date?
Abbott Laboratories's next earnings date is July 18, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NuScale the Best Nuclear Stock to Buy?
NuScale Power (NYSE:SMR) is a nuclear power startup that has…
Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 42x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 50x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
AMBA alert for Jun 25
Ambarella [AMBA] is up 4.36% over the past day.
Buy
65
EXOD alert for Jun 25
Exodus Movement [EXOD] is down 9.63% over the past day.
Buy
78
SMR alert for Jun 25
NuScale Power [SMR] is down 10.59% over the past day.
